Msefsl

CLOSE X

Risk Disclosures on Derivatives

>9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
>On an average, loss makers registered net trading loss close to ₹ 50,000.
>Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
>Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.

ISHITA DRUGS & INDUSTRIES LTD.

NSE : NABSE : 524400ISIN CODE : INE806D01016Industry : Pharmaceuticals & DrugsHouse : Private

BSE79.505.37 (+7.24 %)

PREV CLOSE ( ) 74.13

OPEN PRICE ( ) 79.99

BID PRICE (QTY) 0.00 (0)

OFFER PRICE (QTY) 0.00 (0)

VOLUME 107

TODAY'S LOW / HIGH ( )79.50 79.99

52 WK LOW / HIGH ( ) 6690.85

NSE

This Company is not listed in NSE

BSE NSE

1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 05-02 1992

Management Info

- Chairman Jagdish Agrawal - Managing Director

Registered Office

Address Survey No 179 / 1,Village : Vasna - Lyava,Taluka : Sanand,
Ahmedabad Dist,
Gujarat-382170

Phone 7226995613-15 / 079 - 40023839

Email ishitadrugs@gmail.com / info@ishitadrugs.com

Website www.ishitadrugs.com

Registrars Details

Bigshare Services Pvt Ltd

Office No. 303, Sun Square Complex,Near Chakradhari Society Bus Stop,Girish Cold Drinks Cross Road, C.G. Road, Navrangpura ,Ahmedabad

Listing : BSE

NEWS

23May Ishita Drugs & Industries submits boar
Ishita Drugs & Industries has informed that pursuant to Regulation 2..

01Mar Ishita Drugs & Industries informs abou
Ishita Drugs & Industries has informed that it enclosed Disclosure u..

27Dec Ishita Drugs & Industries informs abou
Pursuant to provision of SEBI (Prohibition of Insider Trading) Regulatio..

09Apr Ishita Drugs & Industries informs abou
Ishita Drugs & Industries has submitted the Confirmation Certificate..

14Apr Ishita Drugs and Industries informs ab
Ishita Drugs and Industries has informed that it enclosed certificate re..

Financials

Rs. in Millions

	QTR Mar 26	ANNUAL 26
Net Profit	1.78	7.77000000000002
Gross Profit	2.8	10.79
Operating Profit	3.14	12.38
Net Sales	30.55	146.6

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Abbott India (BSE) 26544.35 (1.52%)	M.Cap ( in Cr)56225.65
Kwality Pharma (BSE) 2500.00 (7.01%)	M.Cap ( in Cr)2575.48
Unichem Lab (BSE) 453.65 (20.00%)	M.Cap ( in Cr)3085.53
Ajanta Pharma (BSE) 3075.00 (2.09%)	M.Cap ( in Cr)38405.21
Caplin Point Lab (BSE) 2311.25 (2.38%)	M.Cap ( in Cr)17526.02

Shareholding Pattern

	PROMOTERS	50.04%
	NON-INSTITUTION	49.96%
	MUTUAL FUNDS/UTI	0%
	FI/BANKS/INSURANCE	0%
	GOVERNMENT	0%
	FII	0%

Mf Holdings

Scheme Name	Hold(%)
No Data Found

Risk Disclosures on Derivatives

Smart Quotes

ISHITA DRUGS & INDUSTRIES LTD.